Coleman RL - Search Results

1

Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies.

Schmeler KM, Wilson GL, Cain K, Munsell MF, Ramirez PT, Soliman PT, Nick AM, Frumovitz M, Coleman RL, Kroll MH, Levenback CF. Schmeler KM, et al. Among authors: coleman rl. Gynecol Oncol. 2013 Feb;128(2):204-8. doi: 10.1016/j.ygyno.2012.11.027. Epub 2012 Nov 28. Gynecol Oncol. 2013. PMID: 23200912 Free PMC article.

2

Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy.

Burke TW, Levenback C, Coleman RL, Morris M, Silva EG, Gershenson DM. Burke TW, et al. Among authors: coleman rl. Gynecol Oncol. 1995 May;57(2):215-20. doi: 10.1006/gyno.1995.1128. Gynecol Oncol. 1995. PMID: 7729737 Clinical Trial.

3

Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy.

Coleman RL, Keeney ED, Freedman RS, Burke TW, Eifel PJ, Rutledge FN. Coleman RL, et al. Gynecol Oncol. 1994 Oct;55(1):29-35. doi: 10.1006/gyno.1994.1242. Gynecol Oncol. 1994. PMID: 7959262

4

Re: Terada et al.: Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 76:40-44, 2000.

Levenback C, Coleman RL, Ansink A, van der Zee AG. Levenback C, et al. Among authors: coleman rl. Gynecol Oncol. 2000 Jun;77(3):484-5. doi: 10.1006/gyno.2000.5832. Gynecol Oncol. 2000. PMID: 10831370 No abstract available.

5

Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer.

Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK, Gershenson DM. Levenback C, et al. Among authors: coleman rl. Gynecol Oncol. 2001 Nov;83(2):276-81. doi: 10.1006/gyno.2001.6374. Gynecol Oncol. 2001. PMID: 11606084 Clinical Trial.

6

Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy.

Levenback C, Coleman RL, Burke TW, Lin WM, Erdman W, Deavers M, Delpassand ES. Levenback C, et al. Among authors: coleman rl. J Clin Oncol. 2002 Feb 1;20(3):688-93. doi: 10.1200/JCO.2002.20.3.688. J Clin Oncol. 2002. PMID: 11821449

7

Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma.

Lea JS, Coleman RL, Garner EO, Duska LR, Miller DS, Schorge JO. Lea JS, et al. Among authors: coleman rl. Gynecol Oncol. 2003 Dec;91(3):558-62. doi: 10.1016/j.ygyno.2003.08.020. Gynecol Oncol. 2003. PMID: 14675676

8

Oral dexamethasone attenuates Doxil-induced palmar-plantar erythrodysesthesias in patients with recurrent gynecologic malignancies.

Drake RD, Lin WM, King M, Farrar D, Miller DS, Coleman RL. Drake RD, et al. Among authors: coleman rl. Gynecol Oncol. 2004 Aug;94(2):320-4. doi: 10.1016/j.ygyno.2004.05.027. Gynecol Oncol. 2004. PMID: 15297168 Clinical Trial.

9

Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.

Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL. Rao GG, et al. Among authors: coleman rl. Gynecol Oncol. 2005 Jan;96(1):168-72. doi: 10.1016/j.ygyno.2004.09.009. Gynecol Oncol. 2005. PMID: 15589596 Clinical Trial.

10

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers.

Coleman RL, Broaddus RR, Bodurka DC, Wolf JK, Burke TW, Kavanagh JJ, Levenback CF, Gershenson DM. Coleman RL, et al. Gynecol Oncol. 2006 Apr;101(1):126-31. doi: 10.1016/j.ygyno.2005.09.041. Epub 2005 Nov 3. Gynecol Oncol. 2006. PMID: 16271384 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

613 results

Search Page

Filters